logo

For the Inventor, By the Inventor

Kawasaki, Japan

Katsumi Maezono

This inventor holds 11 USPTO granted patents and 2 published patent applications. Top assignee: Ajinomoto Co., Ltd.. Active years: 1996-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsumi Maezono. Retrieved from https://idiyas.com/inventor/katsumi-maezono

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 9.1

Average Co-Inventor Count = 7.1

ph-index = 5

Forward Citations = 67(Granted Patents)


Company Filing History:

goldMedal11 out of 1,953 
 
Ajinomoto Co., Ltd.
 patents

Years Active: 1996-2011

Loading Chart...
11 patents (USPTO):Explore Patents
1. 7994353 - PPAR activity regulators (2011-08-09),
2. 7956041 - Prophylactic and therapeutic agent of diabetes mellitus (2011-06-07),
3. 7732637 - Acylamide compounds having secretagogue or inducer activity of adiponectin (2010-06-08),
4. 7728158 - PPAR activity regulators (2010-06-01),
5. 7645787 - Pyrazole derivatives and diabetic medicine containing them (2010-01-12),
6. 7256209 - Pyrazole derivatives and diabetic medicine containing them (2007-08-14),
7. 7247616 - Pyrazole derivatives and diabetic medicine containing them (2007-07-24),
8. 7015201 - Pyrazole derivatives and diabetic medicine containing them (2006-03-21),
9. 6908905 - N-substituted pyrazole-O-glycoside derivatives and therapeutic agent for diabetes containing the same (2005-06-21),
10. 6815428 - Pyrazole derivatives and diabetic medicine containing them (2004-11-09),
11. 5580903 - Liver regeneration accelerator (1996-12-03),

Title: Innovations of Katsumi Maezono

Introduction

Katsumi Maezono is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of medical science, particularly in the development of treatments for diabetes and related metabolic disorders. With a total of 11 patents to his name, Maezono's work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

One of Maezono's latest patents focuses on PPAR (peroxisome proliferator-activated receptor) activity regulators. This invention provides regulators that can be widely used for improving insulin resistance and preventing or treating various diseases such as diabetes, metabolic syndromes, hyperlipemia, high blood pressure, vascular disorders, inflammation, hepatitis, fatty liver, liver fibrosis, NASH (non-alcoholic steatohepatitis), and obesity. Another significant patent is a prophylactic and therapeutic agent for diabetes mellitus. This invention includes a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent, which can ameliorate hyperglycemia after meals, between meals, and during fasting.

Career Highlights

Katsumi Maezono is currently associated with Ajinomoto Co., Ltd., a company known for its innovative approaches in food and health products. His work at Ajinomoto has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.

Collaborations

Some of Maezono's notable coworkers include Toshihiro Hatanaka and Koji Ohsumi. Their collaborative efforts have contributed to the advancement of research and development in the areas of diabetes and metabolic health.

Conclusion

Katsumi Maezono's innovative work in the field of diabetes treatment showcases his dedication to improving health outcomes for individuals affected by metabolic disorders. His patents reflect a commitment to scientific advancement and the potential for significant medical breakthroughs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…